CN102191306A - Enzymatic preparation method for antihypertensive peptides from jellyfish - Google Patents
Enzymatic preparation method for antihypertensive peptides from jellyfish Download PDFInfo
- Publication number
- CN102191306A CN102191306A CN2011101002208A CN201110100220A CN102191306A CN 102191306 A CN102191306 A CN 102191306A CN 2011101002208 A CN2011101002208 A CN 2011101002208A CN 201110100220 A CN201110100220 A CN 201110100220A CN 102191306 A CN102191306 A CN 102191306A
- Authority
- CN
- China
- Prior art keywords
- jellyfish
- enzyme
- controlled
- temperature
- enzymolysis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000242583 Scyphozoa Species 0.000 title claims abstract 29
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract 14
- 238000002360 preparation method Methods 0.000 title claims abstract 6
- 230000003276 anti-hypertensive effect Effects 0.000 title abstract 4
- 230000002255 enzymatic effect Effects 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000790 Enzymes Proteins 0.000 claims abstract 9
- 102000004190 Enzymes Human genes 0.000 claims abstract 9
- 229940088598 enzyme Drugs 0.000 claims abstract 9
- 102000004169 proteins and genes Human genes 0.000 claims abstract 6
- 108090000623 proteins and genes Proteins 0.000 claims abstract 6
- 102000057297 Pepsin A Human genes 0.000 claims abstract 5
- 108090000284 Pepsin A Proteins 0.000 claims abstract 5
- 238000010612 desalination reaction Methods 0.000 claims abstract 5
- 239000012528 membrane Substances 0.000 claims abstract 5
- 229940111202 pepsin Drugs 0.000 claims abstract 5
- 239000012535 impurity Substances 0.000 claims abstract 4
- 239000002994 raw material Substances 0.000 claims abstract 3
- 238000001728 nano-filtration Methods 0.000 claims abstract 2
- 239000000843 powder Substances 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims 4
- 239000007788 liquid Substances 0.000 claims 3
- 238000001035 drying Methods 0.000 claims 2
- 230000007062 hydrolysis Effects 0.000 claims 2
- 238000006460 hydrolysis reaction Methods 0.000 claims 2
- 239000002002 slurry Substances 0.000 claims 2
- 238000005507 spraying Methods 0.000 claims 2
- 210000002784 stomach Anatomy 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- 229940037003 alum Drugs 0.000 claims 1
- 239000012141 concentrate Substances 0.000 claims 1
- 230000008030 elimination Effects 0.000 claims 1
- 238000003379 elimination reaction Methods 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 238000009413 insulation Methods 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 108090000526 Papain Proteins 0.000 abstract 2
- 239000004365 Protease Substances 0.000 abstract 2
- 241000700159 Rattus Species 0.000 abstract 2
- 229940055729 papain Drugs 0.000 abstract 2
- 235000019834 papain Nutrition 0.000 abstract 2
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 230000036772 blood pressure Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000002474 experimental method Methods 0.000 abstract 1
- 238000004108 freeze drying Methods 0.000 abstract 1
- 230000001631 hypertensive effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000005374 membrane filtration Methods 0.000 abstract 1
- 238000001694 spray drying Methods 0.000 abstract 1
- 238000005406 washing Methods 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明涉及一种海蜇降压肽的酶法制备方法。其是选取新鲜海蜇或矾制海蜇为原料,经脱盐、洗净后进行研磨处理;调节海蜇浆的蛋白质浓度为1%~3%;调整pH值为2~3.5,控温35~40℃,加入胃蛋白酶保温酶解4~6h,胃蛋白酶的用量为每克蛋白质加入2000~4000u;再将海蜇胃蛋白酶水解液调整pH值为5~6,控温50~55℃,加入木瓜蛋白酶酶解1~3h,木瓜蛋白酶用量为每克蛋白质加入2000~4000u;酶灭活;再经膜过滤除杂、纳滤膜脱盐、浓缩、喷雾干燥或冷冻干燥得到海蜇降压肽粉。本发明制备的海蜇降压肽经SHR大鼠(原发性高血压大鼠)口服实验证明具有较好的辅助降血压功效。本发明生产工艺先进,可操作性强,蛋白质酶解完全,产品质量可控。The invention relates to an enzymatic preparation method of jellyfish antihypertensive peptide. It selects fresh jellyfish or alum-made jellyfish as raw materials, grinds them after desalination and washing; adjusts the protein concentration of the jellyfish pulp to 1% to 3%; adjusts the pH value to 2 to 3.5, and controls the temperature to 35 to 40°C. Add pepsin to keep warm for 4-6 hours, and the dosage of pepsin is 2000-4000u per gram of protein; then adjust the pH value of jellyfish pepsin hydrolyzate to 5-6, control the temperature at 50-55°C, and add papain for enzymolysis 1 to 3 hours, the dosage of papain is 2000 to 4000u per gram of protein; the enzyme is inactivated; then the jellyfish antihypertensive peptide powder is obtained through membrane filtration to remove impurities, nanofiltration membrane desalination, concentration, spray drying or freeze drying. The jellyfish antihypertensive peptide prepared by the invention is proved to have good auxiliary effect of lowering blood pressure through oral experiments on SHR rats (essentially hypertensive rats). The invention has advanced production technology, strong operability, complete protein enzymolysis and controllable product quality.
Description
技术领域technical field
本发明涉及一种肽的一般制备方法,尤其是一种通过酶法水解获得海蜇胶原蛋白肽液,再经分离、浓缩、干燥得到海蜇降压肽粉的海蜇降压肽的酶法制备方法。The invention relates to a general preparation method of peptides, in particular to an enzymatic preparation method of jellyfish antihypertensive peptide obtained by enzymatically hydrolyzing jellyfish collagen peptide liquid, and then separating, concentrating and drying to obtain jellyfish antihypertensive peptide powder.
背景技术Background technique
海蜇,又称水母,为海生的肠腔动物,其不仅种类多,数量大,而且分布广,是海洋浮游动物群落的重要组成部分。海蜇营养极为丰富,其体内含有较高的蛋白质及钙、磷、碘、铁等无机盐,素有“水产瑰宝”之美称。海蜇不仅可以食用,而且还是一味治病良药。《本草纲目》中所述:海蜇有清热解毒、化痰软坚、降压消肿等功能,对气管炎、哮喘、高血压、胃溃疡等症均有疗效。因此,海蜇作为一种医食同源的大型生物,其有着重要的经济和食用价值。Jellyfish, also known as jellyfish, is a marine coelomate. It not only has many types and large numbers, but also has a wide distribution. It is an important part of marine zooplankton communities. Jellyfish is extremely nutritious, and its body contains high protein and inorganic salts such as calcium, phosphorus, iodine, iron, etc., and is known as the "treasure of aquatic products". Jellyfish is not only edible, but also a good medicine for curing diseases blindly. According to "Compendium of Materia Medica": jellyfish has the functions of clearing away heat and detoxification, reducing phlegm and softening hardness, reducing blood pressure and reducing swelling, and has curative effects on bronchitis, asthma, hypertension, gastric ulcer and other diseases. Therefore, jellyfish, as a large organism with the same source of medicine and food, has important economic and food value.
制备活性肽的方法主要有:直接提取、体外降解和利用重组DNA技术、酶法或化学法合成活性肽。体外水解蛋白质制备活性肽有三条工艺路线:酸水解、碱水解和酶法水解。前二者方法简单,但存在营养和毒理方面的有害效应,因此在食品加工中的应用受到了极大的限制。蛋白质的酶法水解一般不会导致营养方面的损失,也不会产生毒理上的问题;同时酶作用具有特异性,可在温和的条件下进行,能耗也低,所以酶法水解在食品加工中经常应用。The methods for preparing active peptides mainly include: direct extraction, in vitro degradation and synthesis of active peptides by using recombinant DNA technology, enzymatic method or chemical method. There are three technological routes for preparing active peptides by hydrolyzing proteins in vitro: acid hydrolysis, alkali hydrolysis and enzymatic hydrolysis. The former two methods are simple, but there are harmful effects in nutrition and toxicity, so their application in food processing is greatly limited. Enzymatic hydrolysis of protein generally does not cause nutritional loss, nor does it cause toxicological problems; at the same time, the enzyme is specific, can be carried out under mild conditions, and the energy consumption is also low, so enzymatic hydrolysis is widely used in food Often used in processing.
而用酶法水解海蛰蛋白质制备海蛰活性肽的技术已有报道,例如:由本申请人申请并于2009年5月6日公开的CN101422195A中国发明专利申请公布说明书中公开的“一种海蜇活性肽酸奶及其制备方法”、2009年5月6日公开的CN101422266A中国发明专利申请公布说明书中公开的“一种海蜇营养液及其制备方法”、2010年3月17日公开的CN101669659A中国发明专利申请公布说明书中公开的“一种海蛰荸荠饮品及其制备方法”、2010年10月20日公开的CN101862375A中国发明专利申请公布说明书中公开的“一种复方海蜇降压冲剂及其制备方法”,上述公开文件中对海蜇原料经脱盐、洗净、破碎、加水稀释后或采用碱性蛋白酶或采用胰蛋白酶进行酶解而获得海蜇多肽液,而后用于制备其他功能制品。所公开的技术中,对海蛰进行酶解均采用的是单酶。而在蛋白质水解中,酶的选择是关键技术,所用酶及分离纯化方法的不同可得到不同的产品,不同的酶解工艺所得的肽产品的活性是不一样的。目前,尚未见到采用双酶水解法制备海蜇降压肽的报道。However, the technology of preparing jellyfish active peptides by enzymatically hydrolyzing jellyfish proteins has been reported, for example: "a kind of jellyfish active peptide" disclosed in the CN101422195A Chinese invention patent application published by the applicant and disclosed on May 6, 2009 Peptide yoghurt and its preparation method", CN101422266A Chinese invention patent application published on May 6, 2009, "a jellyfish nutrient solution and its preparation method" disclosed in the publication specification of CN101422266A Chinese invention patent application published on March 17, 2010, CN101669659A Chinese invention patent published on March 17, 2010 "A jellyfish and water chestnut drink and its preparation method" disclosed in the application publication specification, "a compound jellyfish antihypertensive granule and its preparation method" disclosed in the publication specification of CN101862375A Chinese invention patent application published on October 20, 2010 , in the above public documents, jellyfish raw materials are desalted, washed, crushed, diluted with water or enzymatically hydrolyzed with alkaline protease or trypsin to obtain jellyfish polypeptide liquid, which is then used to prepare other functional products. In the disclosed technology, a single enzyme is used for enzymatic hydrolysis of jellyfish. In protein hydrolysis, the choice of enzyme is the key technology. Different enzymes and separation and purification methods can be used to obtain different products. The activity of peptide products obtained by different enzymatic hydrolysis processes is different. At present, there is no report on the preparation of jellyfish antihypertensive peptide by double-enzyme hydrolysis.
发明内容Contents of the invention
为了克服现有技术中的不足,本发明提供了一种生产工艺先进、产品质量可控、蛋白质酶解完全、所得的海蜇肽活性高的海蜇降压肽的酶法制备方法。In order to overcome the deficiencies in the prior art, the invention provides an enzymatic preparation method of jellyfish antihypertensive peptide with advanced production technology, controllable product quality, complete enzymatic hydrolysis of protein, and high activity of the obtained jellyfish peptide.
本发明解决其技术问题所采用的技术方案是:一种海蜇降压肽的酶法制备方法,其特征在于:经过下列步骤The technical scheme adopted by the present invention to solve the technical problem is: an enzymatic preparation method of jellyfish antihypertensive peptide, characterized in that: through the following steps
(a)原料的处理 选取新鲜海蜇或矾制海蜇为原料,清水浸泡脱盐至盐分<5%,洗净后采用胶体磨进行研磨处理,所得海蜇浆颗粒细度控制在2~5um;(a) Processing of raw materials Select fresh jellyfish or alum-made jellyfish as raw materials, soak in water to desalinate until the salt content is less than 5%, and use a colloid mill to grind after washing, so that the particle size of the obtained jellyfish pulp is controlled at 2-5um;
(b)第一步酶解 测定步骤(a)所得海蜇浆的蛋白质含量,加水调整蛋白质的质量浓度为1%~3%;调整pH值为2~3.5,控制温度为35~40℃,加入胃蛋白酶,胃蛋白酶的用量为每克蛋白质加入2000~4000u的胃蛋白酶,保温酶解4~6h,得海蜇胃蛋白酶水解液;(b) The first step of enzymatic hydrolysis to measure the protein content of the jellyfish pulp obtained in step (a), add water to adjust the protein mass concentration to 1% to 3%; adjust the pH value to 2 to 3.5, control the temperature to 35 to 40°C, add Pepsin, the dosage of pepsin is to add 2000-4000u of pepsin per gram of protein, and keep it warm for 4-6 hours to get jellyfish pepsin hydrolyzate;
(c)第二步酶解 将步骤(b)得到的海蜇胃蛋白酶水解液调整pH值为5~6,控制温度为50~55℃,加入木瓜蛋白酶,木瓜蛋白酶用量为每克蛋白质加入2000~4000u的木瓜蛋白酶,酶解1~3h,得海蜇双酶酶解液;(c) The second step of enzymatic hydrolysis Adjust the pH value of the jellyfish pepsin hydrolyzate obtained in step (b) to 5-6, control the temperature at 50-55 ° C, add papain, the amount of papain is 2000-2000 per gram of protein 4000u of papain, hydrolyzed for 1 to 3 hours to get jellyfish dual-enzyme hydrolyzate;
(d)酶灭活 将步骤(c)得到的海蜇双酶酶解液加热至90~100℃,保持10~20分钟,进行酶灭活,得灭酶海蜇双酶酶解液;(d) Enzyme inactivation Heat the jellyfish double-enzyme hydrolyzate obtained in step (c) to 90-100°C, keep it for 10-20 minutes, and perform enzyme inactivation to obtain the enzymatically inactivated jellyfish double-enzyme hydrolyzate;
(e)去杂、脱盐 将步骤(d)得到的灭酶海蜇双酶酶解液经管式膜去除杂质,然后采用150~300截留分子质量的纳滤膜脱盐,并进行浓缩,得海蜇降压肽浓缩液,该海蜇降压肽浓缩液的可溶性固形物含量为15%~20%;(e) Removal of impurities and desalination The enzyme-inactivated jellyfish double-enzyme hydrolyzate obtained in step (d) is passed through a tubular membrane to remove impurities, and then desalted with a nanofiltration membrane with a molecular mass cut-off of 150-300, and concentrated to obtain jellyfish antihypertensive Peptide concentrate, the jellyfish antihypertensive peptide concentrate has a soluble solid content of 15% to 20%;
(f)干燥 将步骤(e)得到的海蜇降压肽浓缩液进行喷雾干燥或冷冻干燥,得到海蜇降压肽粉。(f) Drying The jellyfish antihypertensive peptide concentrate obtained in step (e) is spray-dried or freeze-dried to obtain jellyfish antihypertensive peptide powder.
所述的将酶液灭后的海蜇双酶酶解液去除杂质的管式膜,其工作孔径为0.1~0.2μm,工作温度控制在30~40℃,进膜压力控制在2.5~3bar,出膜压力控制在0.8~1.0bar。The jellyfish dual-enzyme enzymatic hydrolysis solution after the enzymatic liquid has been extinguished is described as a tubular membrane for removing impurities. Membrane pressure is controlled at 0.8-1.0 bar.
所述的将海蜇降压肽浓缩液所进行的喷雾干燥,其进风温度控制在185℃~190℃,出风温度控制在75~80℃,喷雾压力为0.4MPa。In the spray drying of the jellyfish antihypertensive peptide concentrate, the air inlet temperature is controlled at 185°C-190°C, the air outlet temperature is controlled at 75-80°C, and the spray pressure is 0.4MPa.
所述的将海蜇降压肽浓缩液所进行的冷冻干燥,其真空度控制在50~133Pa,加热板温度:20℃250min/40℃400min/30℃直到冻干物料恒重;For the freeze-drying of the jellyfish antihypertensive peptide concentrate, the vacuum degree is controlled at 50-133Pa, and the heating plate temperature is: 20°C 250min/40°C 400min/30°C until the freeze-dried material has a constant weight;
冷阱温度控制在-40℃~-50℃。The temperature of the cold trap is controlled at -40°C to -50°C.
本发明是以鲜海蜇或矾制海蜇为原料,脱盐、研磨后,分别用胃蛋白酶和木瓜蛋白酶分步酶解得到海蜇蛋白水解肽液,然后通过膜过滤除杂、纳滤膜脱盐分离得到海蜇降压肽液,再经浓缩、喷雾干燥或冷冻干燥得到海蜇降压肽粉。本发明制备的海蜇降压肽经SHR大鼠(原发性高血压大鼠)口服实验证明具有较好的辅助降血压功效。该海蜇降压肽的生产工艺先进,可操作性强,产品质量可控,蛋白质酶解完全,所得的海蜇降压肽粉呈白色或淡黄色,活性高,易溶于水,可用于食品和医疗保健等领域。The present invention uses fresh jellyfish or alum-made jellyfish as raw materials, after desalination and grinding, pepsin and papain are enzymatically hydrolyzed to obtain jellyfish proteolytic peptide liquid, and then the jellyfish is obtained by membrane filtration to remove impurities and nanofiltration membrane desalination and separation The antihypertensive peptide solution is concentrated, spray-dried or freeze-dried to obtain jellyfish antihypertensive peptide powder. The jellyfish antihypertensive peptide prepared by the invention is proved to have good auxiliary effect of lowering blood pressure through oral experiments on SHR rats (essentially hypertensive rats). The production technology of the jellyfish antihypertensive peptide is advanced, the operability is strong, the product quality is controllable, and the protein is completely enzymatically hydrolyzed. The jellyfish antihypertensive peptide powder obtained is white or light yellow, has high activity, is easily soluble in water, and can be used in food and medicine. fields such as healthcare.
具体实施方式Detailed ways
下面结合实施例对本发明做进一步详细说明。The present invention will be described in further detail below in conjunction with the examples.
实施例1Example 1
(a)原料的处理 称取500kg新鲜的海蜇为原料,清水浸泡脱盐至盐分为3%,清洗干净后采用胶体磨进行研磨处理,所得海蜇浆颗粒细度控制在3.5um;(a) Processing of raw materials Weigh 500kg of fresh jellyfish as raw material, soak in clear water to desalinate until the salt content is 3%, after cleaning, use a colloid mill for grinding treatment, and the particle size of the obtained jellyfish pulp is controlled at 3.5um;
(b)第一步酶解 测定步骤(a)所得海蜇浆的的水分和蛋白质含量,根据测定结果,加水调整蛋白质的质量浓度为2%;加酸调整pH值为3.26,控制温度为37℃,加入胃蛋白酶,胃蛋白酶的用量为每克蛋白质加入3000u的胃蛋白酶,保温酶解4h,得海蜇胃蛋白酶水解液;(b) The first step of enzymatic hydrolysis Measure the water and protein content of the jellyfish pulp obtained in step (a). According to the measurement results, add water to adjust the protein mass concentration to 2%; add acid to adjust the pH value to 3.26, and control the temperature to 37 ° C. , add pepsin, the dosage of pepsin is to add 3000u pepsin per gram of protein, keep warm for 4 hours, and get jellyfish pepsin hydrolyzate;
(c)第二步酶解 将步骤(b)得到的海蜇胃蛋白酶水解液的pH值用碱溶液调整至5.02,温度升至50℃,加入木瓜蛋白酶,木瓜蛋白酶用量为每克蛋白质加入4000u的木瓜蛋白酶,酶解1h,得海蜇双酶酶解液;(c) The second step of enzymatic hydrolysis Adjust the pH value of the jellyfish pepsin hydrolyzate obtained in step (b) to 5.02 with an alkaline solution, raise the temperature to 50°C, add papain, the amount of papain is 4000u per gram of protein Papain, enzymatically hydrolyzed for 1 hour, to obtain jellyfish dual-enzyme hydrolyzate;
(d)酶灭活 将步骤(c)得到的海蜇双酶酶解液加热至95℃,保持15分钟,进行酶灭活,得灭酶的海蜇双酶酶解液;(d) Enzyme inactivation Heat the jellyfish double-enzyme hydrolyzate obtained in step (c) to 95°C, keep it for 15 minutes, and perform enzyme inactivation to obtain the enzymatically inactivated jellyfish double-enzyme hydrolyzate;
(e)去杂、脱盐 将步骤(d)得到的灭酶海蜇双酶酶解液经管式膜去除杂质,其中管式膜工作孔径为0.15μm,工作温度控制在35℃,进膜压力控制在2.5bar,出膜压力控制在0.9bar。然后采用250截留分子质量的纳滤膜脱盐,脱盐的同时进行浓缩,所得到的浓缩液可进一步采用真空浓缩,得海蜇降压肽浓缩液,该海蜇降压肽浓缩液的可溶性固形物含量为20%;(e) Removal of impurities and desalination The enzyme-inactivated jellyfish double-enzyme hydrolyzate obtained in step (d) is passed through a tubular membrane to remove impurities, wherein the working pore diameter of the tubular membrane is 0.15 μm, the working temperature is controlled at 35°C, and the membrane inlet pressure is controlled at 2.5bar, the membrane outlet pressure is controlled at 0.9bar. Then use a nanofiltration membrane with a molecular weight cut-off of 250 for desalting, and concentrate while desalting, and the obtained concentrated solution can be further concentrated in a vacuum to obtain a jellyfish antihypertensive peptide concentrated solution. The soluble solid content of the jellyfish antihypertensive peptide concentrated solution is 20%;
(f)干燥 将步骤(e)得到的海蜇降压肽浓缩液采用冷冻干燥的方式进行干燥,冷冻干燥的工作条件为:真空度控制在100Pa,加热板温度:20℃250min/40℃400min/30℃直到冻干物料恒重;冷阱温度控制在-45℃。得到海蜇降压肽粉3.5kg,根据体外ACE抑制率测定,其IC50为0.4mg/mL。(f) Drying The jellyfish antihypertensive peptide concentrate obtained in step (e) is dried by freeze-drying. The working conditions of freeze-drying are: vacuum degree is controlled at 100Pa, heating plate temperature: 20°C 250min/40°C 400min/ 30°C until the freeze-dried material has constant weight; the temperature of the cold trap is controlled at -45°C. 3.5 kg of jellyfish antihypertensive peptide powder was obtained, and its IC 50 was 0.4 mg/mL according to the determination of ACE inhibition rate in vitro.
实施例2Example 2
(a)原料的处理 称取取500kg的矾制海蜇为原料,清水浸泡、复水、脱盐至盐分<5%,流水清洗干净后采用胶体磨进行研磨处理,所得海蜇浆颗粒细度控制在2um;(a) Processing of raw materials Weigh 500kg of alum-made jellyfish as raw material, soak in clean water, rehydrate, desalinate until the salt content is less than 5%, clean it with running water, and use a colloid mill to grind it. The particle size of the obtained jellyfish pulp is controlled at 2um ;
(b)第一步酶解 测定步骤(a)所得海蜇浆的的水分和蛋白质含量,根据测定结果,加水调整蛋白质的质量浓度为3%;加酸调整pH值为2,控制温度为35℃,加入胃蛋白酶,胃蛋白酶的用量为每克蛋白质加入4000u的胃蛋白酶,保温酶解5h,得海蜇胃蛋白酶水解液;(b) The first step of enzymatic hydrolysis Measure the water and protein content of the jellyfish pulp obtained in step (a). According to the measurement results, add water to adjust the protein mass concentration to 3%; add acid to adjust the pH value to 2, and control the temperature to 35°C , add pepsin, the dosage of pepsin is to add 4000u of pepsin per gram of protein, heat preservation enzymolysis for 5h, get jellyfish pepsin hydrolyzate;
(c)第二步酶解 将步骤(b)得到的海蜇胃蛋白酶水解液的pH用碱溶液调整至6,控制温度为55℃,加入木瓜蛋白酶,木瓜蛋白酶用量为每克蛋白质加入3500u的木瓜蛋白酶,酶解2h,得海蜇双酶酶解液;(c) The second step of enzymatic hydrolysis Adjust the pH of the jellyfish pepsin hydrolyzate obtained in step (b) to 6 with an alkaline solution, control the temperature at 55°C, add papain, the amount of papain is 3500u of papaya per gram of protein Protease, enzymatic hydrolysis for 2 hours, to obtain jellyfish dual-enzyme hydrolyzate;
(d)酶灭活 将步骤(c)得到的海蜇双酶酶解液加热至100℃,保持10分钟,进行酶灭活,得灭酶的海蜇双酶酶解液;(d) Enzyme inactivation Heat the jellyfish double-enzyme hydrolyzate obtained in step (c) to 100°C, keep it for 10 minutes, and perform enzyme inactivation to obtain the enzymatically inactivated jellyfish double-enzyme hydrolyzate;
(e)去杂、脱盐 将步骤(d)得到的灭酶海蜇双酶酶解液经管式膜去除杂质,其中管式膜的工作孔径为0.2μm,工作温度控制在30℃,进膜压力控制在3bar,出膜压力控制在1.0bar。然后采用300截留分子质量的纳滤膜脱盐,脱盐的同时进行浓缩,得到的浓缩液进一步采用真空浓缩方式进行浓缩,得海蜇降压肽浓缩液,该海蜇降压肽浓缩液的可溶性固形物含量为15%;(e) Removal of impurities and desalination The enzyme-inactivated jellyfish double-enzyme hydrolyzate obtained in step (d) is passed through a tubular membrane to remove impurities, wherein the working pore size of the tubular membrane is 0.2 μm, the working temperature is controlled at 30°C, and the membrane inlet pressure is controlled. At 3bar, the exit membrane pressure is controlled at 1.0bar. Then use a nanofiltration membrane with a molecular weight cut-off of 300 for desalting, and concentrate while desalting, and the obtained concentrate is further concentrated by vacuum concentration to obtain a jellyfish antihypertensive peptide concentrated solution. The soluble solid content of the jellyfish antihypertensive peptide concentrated solution 15%;
(f)干燥 将步骤(e)得到的海蜇降压肽浓缩液进行喷雾干燥,喷雾干燥时其进风温度控制在190℃,出风温度控制在75℃,喷雾压力为0.4MPa,得到海蜇降压肽粉4.0kg,根据体外ACE抑制率测定,其IC50为0.5mg/mL。(f) Drying The jellyfish antihypertensive peptide concentrated solution obtained in step (e) is spray-dried. During spray drying, the air inlet temperature is controlled at 190° C., the air outlet temperature is controlled at 75° C., and the spray pressure is 0.4 MPa to obtain jellyfish antihypertensive peptide. Pressed peptide powder 4.0kg, according to the determination of ACE inhibition rate in vitro, its IC50 is 0.5mg/mL.
实施例3Example 3
(a)原料的处理 称取300kg矾制海蜇为原料,清水浸泡、复水、脱盐至盐分<4%,流水洗净后采用胶体磨进行研磨处理,所得海蜇浆颗粒细度控制在5um;(a) Processing of raw materials Weigh 300kg of jellyfish made from alum as raw material, soak in water, rehydrate, desalinate until the salt content is less than 4%, wash with running water, and use a colloid mill for grinding, and the particle size of the obtained jellyfish pulp is controlled at 5um;
(b)第一步酶解 测定步骤(a)所得海蜇浆的水分和蛋白质含量,加水调整蛋白质的质量浓度为1%;加酸调整pH值为3,控制温度为40℃,加入胃蛋白酶,胃蛋白酶的用量为每克蛋白质加入2000u的胃蛋白酶,保温酶解6h,得海蜇胃蛋白酶水解液;(b) The first step of enzymatic hydrolysis to determine the moisture and protein content of the jellyfish pulp obtained in step (a), adding water to adjust the protein mass concentration to 1%; adding acid to adjust the pH value to 3, controlling the temperature to 40°C, adding pepsin, The dosage of pepsin is to add 2000u of pepsin per gram of protein, and keep it warm for 6 hours to get jellyfish pepsin hydrolyzate;
(c)第二步酶解 将步骤(b)得到的海蜇胃蛋白酶水解液用碱溶液调整pH值至5.5,控制温度为52℃,加入木瓜蛋白酶,木瓜蛋白酶用量为每克蛋白质加入2000u的木瓜蛋白酶,酶解3h,得海蜇双酶酶解液;(c) The second step of enzymatic hydrolysis Adjust the pH value of the jellyfish pepsin hydrolyzate obtained in step (b) to 5.5 with alkaline solution, control the temperature at 52°C, add papain, the amount of papain is 2000u of papaya per gram of protein Protease, enzymatic hydrolysis for 3 hours, to obtain jellyfish dual-enzyme hydrolyzate;
(d)酶灭活 将步骤(c)得到的海蜇双酶酶解液加热至90℃,保持20分钟,进行酶灭活,得灭酶海蜇双酶酶解液;(d) Enzyme inactivation Heat the jellyfish double-enzyme hydrolyzate obtained in step (c) to 90°C, keep it for 20 minutes, and perform enzyme inactivation to obtain the enzymatically inactivated jellyfish double-enzyme hydrolyzate;
(e)去杂、脱盐 将步骤(d)得到的灭酶海蜇双酶酶解液经管式膜去除杂质,其管式膜的工作孔径为0.1μm,工作温度控制在40℃,进膜压力控制在2.8bar,出膜压力控制在0.8bar。然后采用150截留分子质量的纳滤膜脱盐,脱盐的同时进行浓缩,得到的浓缩液采用真空浓缩方式进一步浓缩,得海蜇降压肽浓缩液,该海蜇降压肽浓缩液的可溶性固形物含量为18%;(e) Impurity removal and desalination The enzyme-inactivated jellyfish double-enzyme hydrolyzate obtained in step (d) is passed through a tubular membrane to remove impurities. The working pore size of the tubular membrane is 0.1 μm, the working temperature is controlled at 40 ° C, and the membrane inlet pressure is controlled. At 2.8bar, the exit membrane pressure is controlled at 0.8bar. Then use a nanofiltration membrane with a molecular weight cut-off of 150 for desalting, and concentrate while desalting, and the obtained concentrated solution is further concentrated by vacuum concentration to obtain a jellyfish antihypertensive peptide concentrated solution. The soluble solid content of the jellyfish antihypertensive peptide concentrated solution is 18%;
(f)干燥 将步骤(e)得到的海蜇降压肽浓缩液进行冷冻干燥,冷冻干燥的工作条件为:真空度控制在133Pa,加热板温度:20℃250min/40℃400min/30℃直到冻干物料恒重;冷阱温度控制在-50℃,得到海蜇降压肽粉2.5kg,根据体外ACE抑制率测定,其IC50为0.4mg/mL。(f) Drying The jellyfish antihypertensive peptide concentrate obtained in step (e) is freeze-dried. The working conditions of freeze-drying are: vacuum degree is controlled at 133Pa, heating plate temperature: 20°C 250min/40°C 400min/30°C until frozen The weight of the dry material was constant; the temperature of the cold trap was controlled at -50°C, and 2.5 kg of jellyfish antihypertensive peptide powder was obtained. According to the determination of ACE inhibition rate in vitro, its IC 50 was 0.4 mg/mL.
采用SHR大鼠模型对所制备的海蜇降压肽粉进行评价,实验结果如表1。The SHR rat model was used to evaluate the prepared jellyfish antihypertensive peptide powder, and the experimental results are shown in Table 1.
表1 各给药组对SHR尾动脉收缩压的影响(mmHg)Table 1 The effect of each administration group on SHR tail artery systolic pressure ( mmHg)
注:与空白对照组相比,*P<0.05,**P<0.01Note: Compared with blank control group, *P<0.05, **P<0.01
与空白对照组相比,海蜇降压肽组大鼠灌胃4周后血压水平均明显降低(P<0.05),而且给药组对大鼠体重无明显影响。海蜇降压肽能够明显降低原发性高血压大鼠的血压。Compared with the blank control group, the blood pressure levels of the rats in the jellyfish antihypertensive peptide group were significantly lowered after 4 weeks of intragastric administration (P<0.05), and the administration group had no significant effect on the body weight of the rats. Jellyfish antihypertensive peptide can significantly reduce the blood pressure of essential hypertensive rats.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011101002208A CN102191306B (en) | 2011-04-09 | 2011-04-09 | Enzymatic preparation method for antihypertensive peptides from jellyfish |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011101002208A CN102191306B (en) | 2011-04-09 | 2011-04-09 | Enzymatic preparation method for antihypertensive peptides from jellyfish |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102191306A true CN102191306A (en) | 2011-09-21 |
CN102191306B CN102191306B (en) | 2013-11-13 |
Family
ID=44600173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011101002208A Active CN102191306B (en) | 2011-04-09 | 2011-04-09 | Enzymatic preparation method for antihypertensive peptides from jellyfish |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102191306B (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102409072A (en) * | 2011-11-29 | 2012-04-11 | 山东好当家海洋发展股份有限公司 | Method for preparing composite antihypertensive peptide by using marine organisms |
CN103340448A (en) * | 2013-06-09 | 2013-10-09 | 中国海洋大学 | Jellyfish crystal jelly and processing method thereof |
CN104498571A (en) * | 2014-12-05 | 2015-04-08 | 中南林业科技大学 | Intermittent preparation method of camellia meal protein antihypertensive peptide |
CN104524541A (en) * | 2014-11-27 | 2015-04-22 | 山东好当家海洋发展股份有限公司 | Jellyfish protein effervescent tablet and preparation method thereof |
CN104774255A (en) * | 2015-04-14 | 2015-07-15 | 山东省科学院生物研究所 | Jellyfis-derived bioactive peptide and preparation method thereof |
CN105037486A (en) * | 2015-08-07 | 2015-11-11 | 国家海洋局第三海洋研究所 | Method for preparing jellyfish active glycoprotein through multi-stage film separation technology |
CN105494839A (en) * | 2015-12-26 | 2016-04-20 | 山东好当家海洋发展股份有限公司 | Rhopilema esculentum polypeptide composite tablet candy and preparation method thereof |
CN106591409A (en) * | 2016-12-30 | 2017-04-26 | 浙江海洋大学 | Squid ink oligopeptide with lipid metabolism regulation function |
CN109548950A (en) * | 2018-12-20 | 2019-04-02 | 水母娘娘海洋生物科技有限公司 | The polypeptide and its preparation process in a kind of aurelia source and application |
CN113812583A (en) * | 2021-08-09 | 2021-12-21 | 庄臣酿酒(福建)有限公司 | A kind of preparation method of jellyfish extract |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101862375A (en) * | 2010-05-26 | 2010-10-20 | 山东好当家海洋发展股份有限公司 | A kind of compound jellyfish antihypertensive granule and preparation method thereof |
-
2011
- 2011-04-09 CN CN2011101002208A patent/CN102191306B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101862375A (en) * | 2010-05-26 | 2010-10-20 | 山东好当家海洋发展股份有限公司 | A kind of compound jellyfish antihypertensive granule and preparation method thereof |
Non-Patent Citations (5)
Title |
---|
XIN LIU 等: "Angiotensin converting enzyme (ACE) inhibitory, antihypertensive and antihyperlipidaemic activities of protein hydrolysates from Rhopilema esculentum", 《FOOD CHEMISTRY》, vol. 134, no. 4, 15 October 2012 (2012-10-15) * |
刘景侠 等: "海蜇降压肽制备工艺及体内降压效果的研究", 《食品科学》, vol. 30, no. 11, 1 June 2009 (2009-06-01) * |
刘景侠: "海蜇降压肽提取工艺研究与效果测定", 《中国优秀硕士学位论文全文数据库 工程科技I辑》, no. 11, 15 November 2009 (2009-11-15) * |
安桂香: "海蜇活性肽的制备及降血压效果的研究", 《中国优秀硕士学位论文全文数据库 工程科技I辑》, no. 3, 15 March 2007 (2007-03-15) * |
张绵松 等: "海蜇血管紧张素转化酶抑制肽的超滤分离", 《食品与药品》, vol. 12, no. 1, 10 January 2010 (2010-01-10) * |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102409072B (en) * | 2011-11-29 | 2014-07-23 | 山东好当家海洋发展股份有限公司 | Method for preparing composite blood pressure lowering peptide by using marine organism |
CN102409072A (en) * | 2011-11-29 | 2012-04-11 | 山东好当家海洋发展股份有限公司 | Method for preparing composite antihypertensive peptide by using marine organisms |
CN103340448A (en) * | 2013-06-09 | 2013-10-09 | 中国海洋大学 | Jellyfish crystal jelly and processing method thereof |
CN104524541A (en) * | 2014-11-27 | 2015-04-22 | 山东好当家海洋发展股份有限公司 | Jellyfish protein effervescent tablet and preparation method thereof |
CN104498571B (en) * | 2014-12-05 | 2017-10-20 | 中南林业科技大学 | A kind of Extracted From Oil-tea-cake protein blood pressure-reducing peptide batch (-type) preparation method |
CN104498571A (en) * | 2014-12-05 | 2015-04-08 | 中南林业科技大学 | Intermittent preparation method of camellia meal protein antihypertensive peptide |
CN104774255A (en) * | 2015-04-14 | 2015-07-15 | 山东省科学院生物研究所 | Jellyfis-derived bioactive peptide and preparation method thereof |
CN104774255B (en) * | 2015-04-14 | 2018-01-02 | 山东省科学院生物研究所 | The biologically active peptide in jellyfish source and preparation method thereof |
CN105037486A (en) * | 2015-08-07 | 2015-11-11 | 国家海洋局第三海洋研究所 | Method for preparing jellyfish active glycoprotein through multi-stage film separation technology |
CN105494839A (en) * | 2015-12-26 | 2016-04-20 | 山东好当家海洋发展股份有限公司 | Rhopilema esculentum polypeptide composite tablet candy and preparation method thereof |
CN106591409A (en) * | 2016-12-30 | 2017-04-26 | 浙江海洋大学 | Squid ink oligopeptide with lipid metabolism regulation function |
CN109548950A (en) * | 2018-12-20 | 2019-04-02 | 水母娘娘海洋生物科技有限公司 | The polypeptide and its preparation process in a kind of aurelia source and application |
CN113812583A (en) * | 2021-08-09 | 2021-12-21 | 庄臣酿酒(福建)有限公司 | A kind of preparation method of jellyfish extract |
CN113812583B (en) * | 2021-08-09 | 2023-12-22 | 庄臣酿酒(福建)有限公司 | Preparation method of jellyfish extract |
Also Published As
Publication number | Publication date |
---|---|
CN102191306B (en) | 2013-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102191306A (en) | Enzymatic preparation method for antihypertensive peptides from jellyfish | |
CN102115774B (en) | Method for preparing plant polypeptide by enzyme process | |
CN103230020B (en) | Preparation method of protein short peptide chelated calcium | |
JP3167723B2 (en) | Method for producing whey protein hydrolyzate | |
WO2021142880A1 (en) | Method for producing clam active peptide | |
CN103052717B (en) | Industrial production method for producing antihypertensive bioactive peptide | |
CN105063153B (en) | A kind of preparation method of food-grade low salt ocean fish oligopeptide powder | |
CN103980347B (en) | Antihypertensive peptide of swim bladder of large yellow croaker and preparation method and use thereof | |
CN102204620B (en) | Method for preparing bitterless protein peptides | |
CN1896267B (en) | Preparation of depressor peptide by silkworm chrysalis | |
CN102409072B (en) | Method for preparing composite blood pressure lowering peptide by using marine organism | |
CN103305576B (en) | Process for preparing corn peptides by taking corn starch sugar residues as raw materials | |
CN102808010A (en) | Method for preparing antihypertensive peptides through enzymolysis of ground meat proteins of tuna | |
CN100535122C (en) | Method for preparing laver polypeptide based on pretreatment of ultrasonic | |
CN105567775A (en) | Production method of fish collagen peptide chelated calcium | |
CN105087734A (en) | Method for preparing collagen powder from fish skin and fish scales | |
CN109943612A (en) | Method for producing high-activity minced fillet and product antifreeze agent by enzymolysis of silver carp scales | |
CN1478420A (en) | Oyster capsule food and preparation method thereof | |
CN105918609A (en) | Preparation method of polypeptide protein powder from salted duck egg white | |
CN100506276C (en) | Production method of cottonseed polypeptide dry powder with antioxidant effect | |
CN106591405A (en) | Preparation method of kelp micromolecular ACE inhibitory peptides with Tyr (tyrosine) at C tail end | |
CN104152520B (en) | Preparation method of walnut polypeptide-zinc chelate with antitumor activity | |
CN112111546B (en) | A kind of industrialized preparation method of phosphatin phosphopeptide and yolk polypeptide | |
CN101215594B (en) | Method for preparing pinctada martensii antihypertensive peptide by continuous enzyme membrane reaction | |
CN111920059B (en) | Soybean ACE inhibitory peptide and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |